Nuwellis receives increased reimbursement rate for Aquadex SmartFlow therapy
The Fly

Nuwellis receives increased reimbursement rate for Aquadex SmartFlow therapy

Nuwellis (NUWE) announces that the Centers for Medicare and Medicaid Services, CMS, will reassign the Aquadex ultrafiltration code to the outpatient reimbursement level most consistent with administration of ultrafiltration therapy and cost of treatment. Effective January 1, 2025, the payment rate will increase 397% from $413 to $1,639 per day.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App